224 related articles for article (PubMed ID: 11117873)
1. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
Shaw MD; Vermeulen M; Murray GD; Pickard JD; Bell BA; Teasdale GM
J Neurosurg; 2000 Dec; 93(6):992-7. PubMed ID: 11117873
[TBL] [Abstract][Full Text] [Related]
2. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
[TBL] [Abstract][Full Text] [Related]
3. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
Shen J; Pan JW; Fan ZX; Xiong XX; Zhan RY
J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
[TBL] [Abstract][Full Text] [Related]
6. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
Vajkoczy P; Meyer B; Weidauer S; Raabe A; Thome C; Ringel F; Breu V; Schmiedek P
J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling.
Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Nowbakht P; Roux S; Kassell N
Stroke; 2012 Jun; 43(6):1463-9. PubMed ID: 22403047
[TBL] [Abstract][Full Text] [Related]
8. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).
Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Marr A; Roux S; Kassell N
Lancet Neurol; 2011 Jul; 10(7):618-25. PubMed ID: 21640651
[TBL] [Abstract][Full Text] [Related]
9. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2).
Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Marr A; Roux S; Kassell N
Acta Neurochir Suppl; 2013; 115():27-31. PubMed ID: 22890639
[TBL] [Abstract][Full Text] [Related]
10. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
Vergouwen MD; Algra A; Rinkel GJ
Stroke; 2012 Oct; 43(10):2671-6. PubMed ID: 22871682
[TBL] [Abstract][Full Text] [Related]
12. Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage.
Juvela S
J Neurosurg; 2000 Mar; 92(3):390-400. PubMed ID: 10701524
[TBL] [Abstract][Full Text] [Related]
13. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage.
Gomis P; Graftieaux JP; Sercombe R; Hettler D; Scherpereel B; Rousseaux P
J Neurosurg; 2010 Mar; 112(3):681-8. PubMed ID: 19522571
[TBL] [Abstract][Full Text] [Related]
15. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.
Senbokuya N; Kinouchi H; Kanemaru K; Ohashi Y; Fukamachi A; Yagi S; Shimizu T; Furuya K; Uchida M; Takeuchi N; Nakano S; Koizumi H; Kobayashi C; Fukasawa I; Takahashi T; Kuroda K; Nishiyama Y; Yoshioka H; Horikoshi T
J Neurosurg; 2013 Jan; 118(1):121-30. PubMed ID: 23039152
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America.
Lanzino G; Kassell NF
J Neurosurg; 1999 Jun; 90(6):1018-24. PubMed ID: 10350246
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.
Lynch JR; Wang H; McGirt MJ; Floyd J; Friedman AH; Coon AL; Blessing R; Alexander MJ; Graffagnino C; Warner DS; Laskowitz DT
Stroke; 2005 Sep; 36(9):2024-6. PubMed ID: 16051891
[TBL] [Abstract][Full Text] [Related]
18. Endothelin receptor antagonists for subarachnoid hemorrhage.
Guo J; Shi Z; Yang K; Tian JH; Jiang L
Cochrane Database Syst Rev; 2012 Sep; (9):CD008354. PubMed ID: 22972119
[TBL] [Abstract][Full Text] [Related]
19. Influence endothelin ETA receptor antagonist--BQ-123--on changes of endothelin-1 level in plasma of rats with acute vasospasm following subarachnoid hemorrhage.
Jośko J; Hendryk S; Jedrzejowska-Szypuła H; Gwóźdź B; Herman ZS; Gawlik R
J Physiol Pharmacol; 1998 Sep; 49(3):367-75. PubMed ID: 9789790
[TBL] [Abstract][Full Text] [Related]
20. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial.
Siironen J; Juvela S; Varis J; Porras M; Poussa K; Ilveskero S; Hernesniemi J; Lassila R
J Neurosurg; 2003 Dec; 99(6):953-9. PubMed ID: 14705720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
